摘要
目的：探讨帕利哌酮与阿立哌唑治疗精神分裂症的疗效与安全性。方法：60例精神分裂症患者随机分为两组，分别给予帕利哌酮与阿立哌唑治疗8周。采用阳性与阴性症状量表（PANSS）、副反应量表（TESS）评定疗效及不良反应。结果：帕利哌酮组显效率80％；阿立哌唑组显效率767％。帕利哌酮组的锥体外系副反应高于阿立哌唑组。结论：帕利哌酮与阿立哌唑治疗精神分裂症的疗效相当。
Objective： To study the efficacy and the adverse reaction of Paliperidone in curing schizophreric Methods：Divide 60 schizophrenia patients into two groups at ran dora. One is given Paliperidone and the other is given Aripiprazole for 8 weeks. Evaluate the efficacy and side effect with PANSS and TESS. Results： the significant effective rate of the first group is 80.0 %, and the other is 76.7 %, Aripiprazole has more side effect in extrapytamidal system tham Paliperidone does. Conclusion： Pallperidone does as well as Aripiprazole in curing schizophrenia
出处
《药物与人》
2014年第10期112-113,共2页
Medicine & People
